Staging ::: VER CORREOS
Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
6.370 / 17.039
#50953

Re: Farmas USA

Yo creo que diluir van a diluir si o si,la pregunta es cuando lo haran :P.

Tienen 150 kilos ahora,14 kilos se fueron en el ultimo trimestre,pero ya avisaron que en el proximo se iran mas,Por ventas sacaron 12,6 kilos,vamos,que va a ser un goteo de cash y caera dilucion en 2015,salvo que nos sorprendan con alguna jugada a lo kowa,pero en bestia,con lo que volvemos a soñar....

Paciencia amigo,no queda otra

#50954

Re: Farmas USA

kubbatta, es muy poca la diferencia entre quemado e ingresos. Hay un año de margen para aumentar ventas y evitar la dilución. Yo lo veo muy posible.
AMRN

#50955

Re: Farmas USA

HZNP

Horizon Pharma (HZNP) Shareholders Approve Vidara Therapeutics Purchase

Horizon Pharma (Nasdaq: HZNP) announced that at its Special Meeting of Stockholders held today, proposals related to Horizon's acquisition of Vidara Therapeutics International plc were approved by Horizon's stockholders.
As previously announced, on March 18, 2014, Horizon Pharma, Inc. ("Horizon"), Vidara Therapeutics Holdings LLC, Vidara Therapeutics International plc, an Irish public limited company ("Vidara"), Hamilton Holdings (USA), Inc., an indirect wholly-owned subsidiary of Vidara ("U.S. HoldCo"), and Hamilton Merger Sub, Inc., a wholly-owned subsidiary of U.S. HoldCo ("Merger Sub"), entered into a Transaction Agreement and Plan of Merger (the "Merger Agreement"). The Merger Agreement provides that, upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Horizon, with Horizon continuing as the surviving corporation and as a wholly-owned, indirect subsidiary of Vidara (the "Merger"), with Vidara changing its name to Horizon Pharma Public Limited Company, or plc ("New Horizon").
Horizon's stockholder approval satisfies certain closing conditions related to the Merger. The Merger remains subject to certain other customary closing conditions and approvals including the substitute listing of New Horizon's ordinary shares on the NASDAQ Stock Market. Horizon expects the closing to occur on September 19th after satisfaction of the remaining closing conditions.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#50956

Re: Farmas USA

AMRN

Cualquier oportunidad es buena para sacar pasta a los accionistas. Además, habrá que pagar al personal en acciones y stock options.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#50958

Re: Farmas USA

Comérnosla.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#50959

Re: Farmas USA

HALO

Se reanuda el ensayo:

Halozyme Therapeutics (Nasdaq: HALO) announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial (S1313). The trial is designed to evaluate Halozyme's investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with modified FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma. The study will resume under a revised protocol, and patient enrollment is anticipated to recommence upon review and approval of the amended protocol by the Independent Review Boards at the participating clinical trial sites.

http://www.streetinsider.com/Corporate+News/Halozyme+Therapeutics+%28HALO%29+Reports+Removal+of+FDA+Clinical+Hold+on+PEGPH20+Phase+1b2/9843773.html?si_client=intbro

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#50960

Re: Farmas USA

Evitarla !! jeje
Ana no seas Cenizo!
=P